Ainos, Inc. - Common Stock (NQ:AIMD)

0.9315 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ainos, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Small-Cap Growth Virtual Investor Conference Agenda Announced for February 7th, 2024

February 06, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms

February 05, 2024

Via ACCESSWIRE

Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7th

February 01, 2024

Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Ainos Announces $1.75 Million Follow-On Funding

January 24, 2024

Via ACCESSWIRE

How Is The Market Feeling About Ainos? ↗

January 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 18, 2024

Via Benzinga

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 10, 2024

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 10, 2024

Via Benzinga

Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week ↗

January 10, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow traded up 0.17% to 37,588.15 while the NASDAQ rose 0.34% to 14,908.42. The S&P...

Via Benzinga

Topics Stocks

Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 09, 2024

Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 09, 2024

Via Benzinga

Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket ↗

January 08, 2024

Shares of LumiraDx Limited (NASDAQ: LMDX) shares fell sharply in pre-market trading. LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th....

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 08, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 08, 2024

It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 05, 2024

Via Benzinga

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 05, 2024

Shares of Applied Therapeutics, Inc.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 05, 2024

Via Benzinga

US Stocks Higher; Payrolls Increase By 216,000 In December ↗

January 05, 2024

U.S. stocks traded higher this morning, following the release of jobs data on Friday. Following the market opening Friday, the Dow traded up 0.08% to 37,470.26 while the NASDAQ rose 0.20% to 14,539.40....

Via Benzinga

Topics Stocks

Why Is Applied Therapeutics (APLT) Stock Down 30% Today? ↗

January 05, 2024

Applied Therapeutics stock is tumbling on Friday as investors react to lackluster results from a Phase 3 clinical trial of AT-001.

Via InvestorPlace

Why Is CISO Global (CISO) Stock Down 14% Today? ↗

January 05, 2024

CISO Global stock is falling on Friday as investors in the company react to a new delisting notice over the low trading price of the shares.

Via InvestorPlace

Why Is Dermata Therapeutics (DRMA) Stock Up 62% Today? ↗

January 05, 2024

Dermata Therapeutics stock is heading higher on Friday as investors of DRMA shares react to a new patent for DMT410 in Japan.

Via InvestorPlace

Topics Intellectual Property

Why Is Ainos (AIMD) Stock Up 157% Today? ↗

January 05, 2024

Ainos stock is up on Friday as shares of AIMD see heavy trading despite a lack of news from the healthcare company today.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 05, 2024

Via Benzinga

Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket ↗

January 05, 2024

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of...

Via Benzinga

Topics Intellectual Property

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 05, 2024

Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning!

Via InvestorPlace

Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement

January 02, 2024

Via ACCESSWIRE

Ainos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of Smell

December 26, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 19, 2023

Via Benzinga

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 18, 2023

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.